Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR+53.2%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
+53.2%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
8.4x
Strong expansion
Streak
4 yr
Consecutive growthAccelerating
PeriodValue
2025110.45%
202460.55%
202332.69%
2022-16.97%
2021-33.52%
202013.11%
20196.75%
20186.01%
201715.98%
201633.74%